Prognostic value of procalcitonin and C-reactive protein clearance rate in septic shock patients
-
摘要: 目的:探讨降钙素原清除率(PCT-c)、C反应蛋白清除率(CRP-c)在脓毒性休克患者28 d内病死率的价值。方法:选取我院在2016-01—2019-02期间收治的223例脓毒性休克患者,根据28 d内的死亡事件分为生存组(165例)与死亡组(58例)。采用酶联荧光法测定血清PCT浓度,采用免疫比浊法测定血清CRP浓度。之后在第2天、第3天、第5天以同样方式测定血清PCT及CRP浓度。计算PCT-c2/1、PCT-c3/1、PCT-c5/1、CRP-c2/1、CRP-c3/1、CRP-c5/1。结果:脓毒性休克患者病死率为26.0%。生存组患者的SOFA评分低于死亡组患者,差异有统计学意义(P<0.05)。死亡组患者第1天、第2天、第3天、第5天的血清PCT及CRP浓度均高于生存组患者,差异有统计学意义(P<0.05)。PCT-c3/1的AUC为0.797,最佳截断值为0.68;CRP-c3/1的AUC为0.802,最佳截断值为0.55。SOFA评分(OR:2.261,95%CI:1.738~2.940)、PCT-c3/1≤0.68(OR:3.544,95%CI:2.324~6.968)及CRP-c3/1≤0.55(OR:3.874,95%CI:1.065~7.099)为脓毒性休克患者死亡的独立危险因素(P<0.05)。结论:PCT-c及CRP-c对于预测28 d内脓毒性休克患者病死率的价值相当且均具有较高的临床价值,建议将其纳入常规的监测指标中,进一步完善该类患者治疗指导方案。Abstract: Objective: To explore the value of procalcitonin clearance rate(PCT-c) and C-reactive protein clearance rate(CRP-c) in the mortality rate of septic shock within 28 days. Method: Two hundred and twenty-three patients with sepsis complicated with septic shock were selected from January 2016 to February 2019 in our hospital. According to the death events within 28 days, they were divided into survival group and death group. Serum PCT concentration was determined by ELISF and serum CRP concentration was determined by immunoturbidimetry. The serum PCT and CRP levels were measured in the same way on day 2, 3 and 5. PCT-c2/1, PCT-c3/1, PCT-c5/1, CRP-c2/1, CRP-c3/1 and CRP-c5/1 were calculated. Result: There were 165 patients in survival group and 58 patients in death group. The mortality rate was 26.0%. The SOFA score of survival group was lower than that of death group(P<0.05). The serum PCT and CRP levels of the dead group on the first day, the second day, the third day and the fifth day were higher than those of the survival group, and the difference was statistically significant(P<0.05). The AUC of PCT-c3/1 is 0.797, the best truncation value is 0.68, the AUC of CRP-c3/1 is 0.802, and the best truncation value is 0.55. SOFA score(OR: 2.261, 95%CI: 1.738-2.940), PCT-c3/1≤0.68(OR: 3.544, 95%CI: 2.324-6.968) and CRP-c3/1≤0.55(OR: 3.874, 95%CI: 1.065-7.099) were independent risk factors for death in sepsis patients with septic shock(P<0.05).Conclusion: PCT-c and CRP-c have similar and high clinical value in predicting the mortality of septic shock within 28 days. It is suggested that PCT-c and CRP-c should be included in routine monitoring indicators to further improve the treatment guidance program for such patients.
-
Key words:
- sepsis /
- procalcitonin /
- C-reactive protein /
- clearance rate /
- death
-
[1] 蒋道慧,张琳,彭松.每搏量变异度在预测老年脓毒性休克患者容量反应性中的价值[J].临床急诊杂志,2017,18(10):783-786.
[2] Bloos F,Marshall JC,Dellinger RP,et al.Multinational,observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation:a multicenter observational study[J].Critical Care,2011,15(2):R88.
[3] Grigoras I,Branisteanu DD,Ungureanu D,et al.Early dynamics of leptin plasma level in surgical critically ill patients.a prospective comparative study[J].Chirurgia,2014,109(1):66-72.
[4] Su LX,Feng L,Song Q,et al.Diagnostic value of dynamics serum sCD163,sTREM-1,PCT,and CRP in differentiating sepsis,severity assessment,and prognostic prediction[J].Mediators Inflamm,2013,2013:1-9.
[5] Andriolo BN,Andriolo RB,Salomao R,et al.Effectiveness and safety of procalcitonin evaluation for reducing mortality in adults with sepsis,severe sepsis or septic shock.[J].Cochrane Database Syst Rev,2017,2017(1):CD010959.
[6] Dellinger RP,Mitchell M.Levy;Andrew Rhodes,et al;The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup.Surviving sepsis campaign:international guidelines for management of severe sepsis and septic shock,2012[J].Intensive Care Med,2013,39(2):165-228.
[7] Gai L,Tong Y,Yan BQ.Research on the diagnostic effect of PCT level in serum on patients with sepsis due to different pathogenic causes[J].Eur Rev Med Pharmacol Sci,2018,22(13):4238-4242.
[8] Oliveira CF,Botoni FA,Oliveira CRA,et al.Procalcitonin versus C-reactive protein for guiding antibiotic therapy in sepsis:a randomized trial[J].Crit Care Med,2013,41(10):2336-2343.
[9] Yoshinaga R,Doi Y,Ayukawa K,et al.High-sensitivity C reactive protein as a predictor of inhospital mortality in patients with cardiovascular disease at an emergency department:a retrospective cohort study[J].BMJ Open,2017,7(10):e015112.
[10] Garnacho-Montero J,Huici-Moreno MJ,Gutiérrez-Pizarraya A,et al.Prognostic and diagnostic value of eosinopenia,C-reactive protein,procalcitonin,and circulating cell-free DNA in critically ill patients admitted with suspicion of sepsis[J].Crit Care,2014,18(3):R116.
[11] Jensen JU,Heslet L,Jensen TH,et al.Procalcitonin increase in early identification of critically ill patients at high risk of mortality[J].Critical Care Med,2006,34(10):2596-2602.
[12] Wacker,Christina,Prkno,et al.Procalcitonin as a diagnostic marker for sepsis:a systematic review and;meta-analysis[J].Lancet Infectious Diseases,2013,13(5):426-435.
[13] Wu Q,Nie J,Wu FX,et al.Prognostic Value of High-Sensitivity C-Reactive Protein,Procalcitonin and Pancreatic Stone Protein in Pediatric Sepsis[J].Medical Science Monitor,2017,23:1533-1539.
[14] Ruiz-Rodríguez JC,Caballero J,Ruiz-Sanmartin A,et al.Usefulness of procalcitonin clearance as a prognostic biomarker in septic shock.A prospective pilot study[J].Medicina Intensiva,2012,36(7);475-480.
[15] Azevedo JD,Torres O,Malafaia O.Procalcitonin as a prognostic biomarker of severe sepsis and septic shock[J].Rev Col Bras Cir,2013,39(6):456-461.
[16] Suberviola B,Castellanos-Ortega A,González-Castro A,ey al.Prognostic value of procalcitonin,C-reactive protein and leukocytes in septic shock[J].Medicina Intensiva,2012,36(3):177-184
[17] Schuetz P,Maurer P,Punjabi V,et al.Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients[J].Critical Care,2013,17(3):R115.
[18] Cui N,Zhang H,Chen Z,et al.Prognostic significance of PCT and CRP evaluation for adult ICU patients with sepsis and septic shock:retrospective analysis of 59 cases[J].J Int Med Res,2019,47(4):1573-1579.
[19] 李娜,李瑞.C-反应蛋白下降率对判断严重脓毒症患者预后的作用[J].新疆医科大学学报,2014,37(08):1005-1007.
计量
- 文章访问数: 131
- PDF下载数: 198
- 施引文献: 0